Cargando…
Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment
Weak T-cell antigen receptor (TCR)-ligand interactions are sufficient to activate naïve CD8(+) T cells, but generally do not result in tumor eradication. How differences in TCR affinity affect the regulation of T-cell function in an immunosuppressive tumor environment has not been investigated. We h...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518496/ https://www.ncbi.nlm.nih.gov/pubmed/23243587 http://dx.doi.org/10.4161/onci.21285 |
_version_ | 1782252562623234048 |
---|---|
author | Bos, Rinke Marquardt, Kristi L. Cheung, Jocelyn Sherman, Linda A. |
author_facet | Bos, Rinke Marquardt, Kristi L. Cheung, Jocelyn Sherman, Linda A. |
author_sort | Bos, Rinke |
collection | PubMed |
description | Weak T-cell antigen receptor (TCR)-ligand interactions are sufficient to activate naïve CD8(+) T cells, but generally do not result in tumor eradication. How differences in TCR affinity affect the regulation of T-cell function in an immunosuppressive tumor environment has not been investigated. We have examined the functional differences of high- vs. low-affinity CD8(+) T cells and we observed that infiltration, accumulation, survival and cytotoxicity within the tumor are severely impacted by the strength of TCR-ligand interactions. In addition, high-affinity CD8(+) T cells were found to exhibit lower expression of inhibitory molecules including PD-1, LAG-3 and NKG2A, thus being less susceptible to suppressive mechanisms. Interferon γ and autocrine interleukin-2 were both found to influence the level of expression of these molecules. Interestingly, although high-affinity CD8(+) T cells were superior to low-affinity CD8(+) T cells in their ability to effect tumor eradication, they could be further improved by the presence of tumor specific CD4(+) T cells. These findings illustrate the importance of both TCR affinity and tumor-specific CD4 help in tumor immunotherapy. |
format | Online Article Text |
id | pubmed-3518496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-35184962012-12-14 Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment Bos, Rinke Marquardt, Kristi L. Cheung, Jocelyn Sherman, Linda A. Oncoimmunology Research Paper Weak T-cell antigen receptor (TCR)-ligand interactions are sufficient to activate naïve CD8(+) T cells, but generally do not result in tumor eradication. How differences in TCR affinity affect the regulation of T-cell function in an immunosuppressive tumor environment has not been investigated. We have examined the functional differences of high- vs. low-affinity CD8(+) T cells and we observed that infiltration, accumulation, survival and cytotoxicity within the tumor are severely impacted by the strength of TCR-ligand interactions. In addition, high-affinity CD8(+) T cells were found to exhibit lower expression of inhibitory molecules including PD-1, LAG-3 and NKG2A, thus being less susceptible to suppressive mechanisms. Interferon γ and autocrine interleukin-2 were both found to influence the level of expression of these molecules. Interestingly, although high-affinity CD8(+) T cells were superior to low-affinity CD8(+) T cells in their ability to effect tumor eradication, they could be further improved by the presence of tumor specific CD4(+) T cells. These findings illustrate the importance of both TCR affinity and tumor-specific CD4 help in tumor immunotherapy. Landes Bioscience 2012-11-01 /pmc/articles/PMC3518496/ /pubmed/23243587 http://dx.doi.org/10.4161/onci.21285 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Research Paper Bos, Rinke Marquardt, Kristi L. Cheung, Jocelyn Sherman, Linda A. Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment |
title | Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment |
title_full | Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment |
title_fullStr | Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment |
title_full_unstemmed | Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment |
title_short | Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment |
title_sort | functional differences between low- and high-affinity cd8(+) t cells in the tumor environment |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518496/ https://www.ncbi.nlm.nih.gov/pubmed/23243587 http://dx.doi.org/10.4161/onci.21285 |
work_keys_str_mv | AT bosrinke functionaldifferencesbetweenlowandhighaffinitycd8tcellsinthetumorenvironment AT marquardtkristil functionaldifferencesbetweenlowandhighaffinitycd8tcellsinthetumorenvironment AT cheungjocelyn functionaldifferencesbetweenlowandhighaffinitycd8tcellsinthetumorenvironment AT shermanlindaa functionaldifferencesbetweenlowandhighaffinitycd8tcellsinthetumorenvironment |